Cost Plus Drugs inked deals with MultiCare Health System, Network Health, Blue Cross and Blue Shield insurers and others ...

An executive order by Trump rolled back some efforts by the Biden administration to control Medicare costs but it didn't change drug price caps.

Preclinical drug evaluation, especially for cardiotoxicity, is a critical stage in the drug development process.

A new fully automated in vivo screening system (AISS) has been developed to transform drug evaluation by enabling rapid, ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

Quartile Reporting is part of Psychemedics’ ongoing efforts to innovate and meet the growing demand for more comprehensive, insightful drug testing data. This enhancement is available to all ...

Screening and then characterizing all ... and can help to identify promising drug candidates faster and at lower cost than before. Monoclonal antibodies are one of the hottest classes of drugs ...